Systemic inflammation and polycyclic aromatic hydrocarbons jointly accelerate lung function decline: Evidence from the Wuhan-Zhuhai cohort

Systemic inflammation has been implicated as an important hallmark of cardiovascular disease, asthma, and aging. However, its adverse effect on lung function in the general population, along with its combined impact with polycyclic aromatic hydrocarbons (PAHs) exposure remains largely unknown. We developed a systemic inflammation score incorporating white blood cell (WBC) count, high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), interleukin-22 (IL-22), and club cell secretory protein-16 (CC16), based on biomarker-lung function associations identified in a panel study of 221 observations (n = 120). Using data from the Wuhan-Zhuhai (WHZH) cohort (5662 observations), we examined the cross-sectional and longitudinal associations of the systemic inflammation score and urinary mono-hydroxylated PAH metabolites (OH-PAHs) with lung function. Each unit increase in the inflammation score was associated with reductions in forced expiratory volume in 1 s (FEV<sub>1</sub>) (-6.94 mL), forced vital capacity (FVC) (-8.03 mL), and peak expiratory flow (PEF) (-14.50 mL/s). Longitudinal analysis revealed that participants with consistently high inflammation scores experienced accelerated annual declines in FEV<sub>1</sub> (-13.41 mL/year), FVC (-19.04 mL/year), and PEF (-93.51 mL/s·year) compared to those with consistently low scores. Although OH-PAHs were not significantly associated with inflammation scores, participants with high levels of both OH-PAHs and inflammation scores exhibited significantly lower lung function (FEV<sub>1</sub>: -132.20 mL; FVC: -155.80 mL) than those with low levels of both. Our findings suggest that systemic inflammation is independently associated with lung function decline, and its combination with PAH exposure accelerates this process. These results highlighted the importance of monitoring systemic inflammation in environmental exposures related respiratory impairment in the general population.

Authors

Institutions

Publication Details

Journal
Ecotoxicology and Environmental Safety
Published
2026-02-01
DOI
https://doi.org/10.1016/j.ecoenv.2026.119787
Primary Topic
Air Quality and Health Impacts
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Systemic inflammation and polycyclic aromatic hydrocarbons jointly accelerate lung function decline: Evidence from the Wuhan-Zhuhai cohort

Yucao Zheng, Zhilin Zheng, Yu Guo, Liangliang Ju et al.
Ecotoxicology and Environmental Safety
Air Quality and Health Impacts
article

Systemic inflammation and polycyclic aromatic hydrocarbons jointly accelerate lung function decline: Evidence from the Wuhan-Zhuhai cohort

Yucao Zheng, Zhilin Zheng, Yu Guo, Liangliang Ju, Quanhong Liu, Jixuan Ma, Dongming Wang, Ming Zhang, Min Zhou, Weihong Chen, Bin Wang
article en

Abstract

Systemic inflammation has been implicated as an important hallmark of cardiovascular disease, asthma, and aging. However, its adverse effect on lung function in the general population, along with its combined impact with polycyclic aromatic hydrocarbons (PAHs) exposure remains largely unknown. We developed a systemic inflammation score incorporating white blood cell (WBC) count, high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), interleukin-22 (IL-22), and club cell secretory protein-16 (CC16), based on biomarker-lung function associations identified in a panel study of 221 observations (n = 120). Using data from the Wuhan-Zhuhai (WHZH) cohort (5662 observations), we examined the cross-sectional and longitudinal associations of the systemic inflammation score and urinary mono-hydroxylated PAH metabolites (OH-PAHs) with lung function. Each unit increase in the inflammation score was associated with reductions in forced expiratory volume in 1 s (FEV<sub>1</sub>) (-6.94 mL), forced vital capacity (FVC) (-8.03 mL), and peak expiratory flow (PEF) (-14.50 mL/s). Longitudinal analysis revealed that participants with consistently high inflammation scores experienced accelerated annual declines in FEV<sub>1</sub> (-13.41 mL/year), FVC (-19.04 mL/year), and PEF (-93.51 mL/s·year) compared to those with consistently low scores. Although OH-PAHs were not significantly associated with inflammation scores, participants with high levels of both OH-PAHs and inflammation scores exhibited significantly lower lung function (FEV<sub>1</sub>: -132.20 mL; FVC: -155.80 mL) than those with low levels of both. Our findings suggest that systemic inflammation is independently associated with lung function decline, and its combination with PAH exposure accelerates this process. These results highlighted the importance of monitoring systemic inflammation in environmental exposures related respiratory impairment in the general population.

Ecotoxicology and Environmental SafetyVol. 311
Huazhong University of Science and Technology (CN)
Good health and well-being
Openalex Percentile: Top 54%
Air Quality and Health Impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.